Speakers Highlight Innovation in Health Care at Annual Jmore Event

Jmore held its fourth annual JBiz “Innovation in Health Care” panel discussion on Oct. 25. Hosted at The Garage at R. House, the event was also streamed on Facebook at facebook.com/jmoreliving.

This year’s speakers were Dr. John B. Chessare, President and Chief Executive Officer of GBMC HealthCare; Jon Hershfield, MFT, Director of The Center for OCD and Anxiety at Sheppard Pratt; Dr. Helen Hughes, Medical Director for Johns Hopkins Medicine’s Office of Telemedicine; Dr. Alan H. Shikani, Chief of Otolaryngology at LifeBridge Sinai Hospital; and Adam Silverman, DPM, Wound Care Medical Director for MVS Wound Care & Hyperbarics.

The speakers discussed the state of health care in this country, new advancements in their fields and the challenges they see.

Gary Stein moderated the hour-long discussion, which also included opening remarks from Lauren Ziegler of Nemphos Braue LLC.

Innovation in Health Care 2022

The event was sponsored by GBMC, John Hopkins Medicine, LifeBridge Health, MVS Woundcare & Hyperbarics, Nemphos Braue LLC, and Sheppard Pratt.

Watch a replay of the event here:

Sponsored By

health care 2022 sponsors

Thank You To

R House Gourmet Girls Studio 83
You May Also Like
Activist Starts Endowment Fund for Individuals with Mobility Issues
John Singer

John Singer wants to help Marylanders of all economic backgrounds to afford ankle foot orthoses.

The KSDS Bridges Experience: From New Student to School Leader
Krieger Schechter Day School

At Krieger Schechter Day School, joining in the later elementary or middle school isn’t a setback -- it’s a launch pad.

Advertisement


Israeli Scientists Lead Fight Against Colorectal Cancer
Hebrew University-Hadassah’s Institute of Dental Science

Colorectal cancer rates are climbing among young people and Ashkenazi Jews.

Greenebaum Foundation Makes $5.5 Million Donation to Cancer Center
Marlene and Stewart Greenebaum

The donation will be directed to help foster research conducted by faculty at the University of Maryland School of Medicine and to advance innovative treatments.